Hologic Announces European CE Mark for LOCalizer Wireless Breast Lesion Localization System
Latest addition to growing portfolio of breast and skeletal health innovations to be featured at ECR 2019 Hologic, Inc. (Nasdaq: HOLX) today announced the granting of a CE Mark to the LOCalizer™ wireless radio frequency identification (RFID) breast lesion localization system. This system is designed for precise and easy marking and targeting of lesions for […]
